Bianucci P, Pastorino G
Minerva Med. 1981 Nov 14;72(45):3013-7.
Two protocols, namely VAME (VCR, ADR, MTX, DEDX) and CMF (CTX, MTX, 5 FU), were used in the treatment of 77 menopausal patients with invasive breast cancer at the Savona Oncological Hospital between December 1976 and November 1980. CR + PR was obtained in 81.25% of those treated with VAME (group 1) and 55.18% of those treated with CMF (group B). The median and overall percentage of survival was higher in group A, and the free interval was longer, especially in patients with PR. This protocol also caused fewer subjective and objective disturbances and is thus regarded as more satisfactory, particularly since the main aim of antiblastic management is to improve and length and the quality of life.
1976年12月至1980年11月期间,萨沃纳肿瘤医院使用了两种方案,即VAME(长春新碱、阿霉素、甲氨蝶呤、地塞米松)和CMF(环磷酰胺、甲氨蝶呤、5-氟尿嘧啶),对77例绝经后浸润性乳腺癌患者进行治疗。接受VAME治疗的患者(A组)中,81.25%获得完全缓解(CR)+部分缓解(PR);接受CMF治疗的患者(B组)中,这一比例为55.18%。A组的中位生存期和总生存率更高,无病间期更长,尤其是PR患者。该方案引起的主观和客观干扰也更少,因此被认为更令人满意,特别是因为抗恶性肿瘤治疗的主要目标是延长生存期和提高生活质量。